Cyclooxygenase-2 gene polymorphisms in an Australian population: Association of the -1195G > A promoter polymorphism with mild asthma

Clinical and Experimental Allergy

Volumn 38, Issue 6, 2008, Pages 913-920

  Shi, J ^a,b,c   Misso, N L ^a,b   Kedda, M A ^a,b,c,f   Horn, J ^a,b,c   Welch, M D ^a,b,c   Duffy, D L ^d   Williams, C ^a,b,c   Thompson, P J ^a,b,e  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Cooperative Research Centre for Asthma and Airways ^*  (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^e SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^f QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Aspirin intolerant asthma; Association study; Asthma; Cyclooxygenase 2; Genetics; Promoter; Prostaglandins; Single nucleotide polymorphism

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2; LUCIFERASE;

ADULT; AGED; ARTICLE; ASTHMA; AUSTRALIA; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FUNCTIONAL ASSESSMENT; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC TRANSFECTION; GENOTYPE; HAPLOTYPE; HELA CELL; HOMOZYGOTE; HUMAN; HUMAN CELL; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; NUCLEOTIDE SEQUENCE; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; ASTHMA; AUSTRALIA; CASE-CONTROL STUDIES; CYCLOOXYGENASE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HELA CELLS; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PLASMIDS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS, DNA; TRANSFECTION;

EID: 44249093486     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2008.02986.x     Document Type: Article

References (40)

1. Tattersfield AE, Knox AJ, Britton JR, Hall IP. Asthma. Lancet 2002 360 : 1313 22.
2. Ober C, Hoffjan S. Asthma genetics 2006: the long and winding road to gene discovery. Genes Immun 2006 7 : 95 100.
3. Castro-Giner F, Kauffmann F, de Cid R, Kogevinas M. Gene-environment interactions in asthma. Occup Environ Med 2006 63 : 776 86.
4. Kiley J, Smith R, Noel P. Asthma phenotypes. Curr Opin Pulm Med 2007 13 : 19 23.
5. Stevenson DD, Szczeklik A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol 2006 118 : 773 86.
6. Hall IP. The pharmacogenetics of asthma. Chest 2006 130 : 1873 8.
7. Park GY, Christman JW. Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases. Am J Physiol Lung Cell Mol Physiol 2006 290 : L797 805.
8. Helliwell RJ, Adams LF, Mitchell MD. Prostaglandin synthases: recent developments and a novel hypothesis. Prostaglandins Leukot Essent Fatty Acids 2004 70 : 101 13.
9. Okano M, Fujiwara T, Yamamoto M et al. Role of prostaglandin D2 and E2 terminal synthases in chronic rhinosinusitis. Clin Exp Allergy 2006 36 : 1028 38.
10. Dubois RN, Abramson SB, Crofford L et al. Cyclooxygenase in biology and disease. FASEB J 1998 12 : 1063 73.
11. Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 1998 38 : 97 120.
12. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular and molecular biology. Annu Rev Biochem 2000 69 : 149 82.
13. Long JA, Fogel-Petrovic M, Knight DA, Thompson PJ, Upham JW. Higher prostaglandin E2 production by dendritic cells from subjects with asthma compared with normal subjects. Am J Respir Crit Care Med 2004 170 : 485 91.
14. Shi J, Misso NL, Duffy DL et al. Cyclooxygenase-1 gene polymorphisms in patients with different asthma phenotypes and atopy. Eur Respir J 2005 26 : 249 56.
15. Demoly P, Jaffuel D, Lequeux N et al. Prostaglandin H synthase 1 and 2 immunoreactivities in the bronchial mucosa of asthmatics. Am J Respir Crit Care Med 1997 155 : 670 5.
16. Demoly P, Crampette L, Lebel B, Campbell AM, Mondain M, Bousquet J. Expression of cyclo-oxygenase 1 and 2 proteins in upper respiratory mucosa. Clin Exp Allergy 1998 28 : 278 83.
17. Watkins DN, Peroni DJ, Lenzo JC, Knight DA, Garlepp MJ, Thompson PJ. Expression and localization of COX-2 in human airways and cultured airway epithelial cells. Eur Respir J 1999 13 : 999 1007.
18. Taha R, Olivenstein R, Utsumi T et al. Prostaglandin H synthase 2 expression in airway cells from patients with asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000 161 : 636 40.
19. Profita M, Sala A, Bonanno A et al. Increased prostaglandin E2 concentrations and cyclooxygenase-2 expression in asthmatic subjects with sputum eosinophilia. J Allergy Clin Immunol 2003 112 : 709 16.
20. Shi J, Misso NL, Duffy DL, Thompson PJ, Kedda M-A. A functional polymorphism in the promoter region of the cyclooxygenase-2 gene is not associated with asthma and atopy in an Australian population. Clin Exp Allergy 2004 34 : 1714 8.
21. -765C in bronchial asthma. J Allergy Clin Immunol 2004 114 : 248 53.
22. Zhang X, Miao X, Tan W et al. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology 2005 129 : 565 76.
23. Kedda MA, Shi J, Duffy D et al. Characterization of two polymorphisms in the leukotriene C4 synthase gene in an Australian population of subjects with mild, moderate, and severe asthma. J Allergy Clin Immunol 2004 113 : 889 95.
24. National Asthma Council of Australia. Asthma management handbook 2002. South Melbourne : National Asthma Council of Australia, 2002.
25. NIH Expert Panel Report II: Guidelines for the diagnosis and management of asthma: National Asthma Education and Prevention Program, National Heart, Lung and Blood Institute. Bethesda, MD : NIH, NIH Publication 1997: 97-4051.
26. Vally H, Taylor ML, Thompson PJ. The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients. Thorax 2002 57 : 569 74.
27. Riva A, Kohane IS. SNPper: retrieval and analysis of human SNPs. Bioinformatics 2002 18 : 1681 5.
28. Tatusova TA, Madden TL. BLAST 2 sequences, a new tool for comparing protein and nucleotide sequences. FEMS Microbiol Lett 1999 174 : 247 50.
29. Heinemeyer T, Wingender E, Reuter I et al. Databases on transcriptional regulation: TRANSFAC, TRRD and compel. Nucleic Acids Res 1998 26 : 362 7.
30. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria : R Foundation for Statistical Computing, 2006 ISBN 3-900051-07-0, URL.
31. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002 70 : 425 34.
32. Ramsay RG, Friend A, Vizantios Y et al. Cyclooxygenase-2, a colorectal cancer nonsteroidal anti-inflammatory drug target, is regulated by cMYB. Cancer Res 2000 60 : 1805 9.
33. Ramsay RG, Barton AL, Gonda TJ. Targeting c-MYB expression in human disease. Expert Opin Ther Target 2003 7 : 235 48.
34. Gauvreau GM, Watson RM, O'Byrne PM. Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation. Am J Respir Crit Care Med 1999 159 : 31 6.
35. Vancheri C, Mastruzzo C, Sortino MA, Crimi N. The lung as a privileged site for the beneficial actions of PGE2. Trends Immunol 2004 25 : 40 6.
36. 2 and dibutyryl cyclic adenosine monophosphate prolong eosinophil survival in vitro. J Allergy Clin Immunol 1999 104 : 153 62.
37. Matsuoka T, Hirata M, Tanaka H et al. Prostaglandin D2 as a mediator of allergic asthma. Science 2000 287 : 2013 7.
38. Sandig H, Pease JE, Sabroe I. Contrary prostaglandins: the opposing roles of PGD2 and its metabolites in leukocyte function. J Leukoc Biol 2007 81 : 372 82.
39. Vignola AM, Bellia V. Transcriptional regulation of COX-2: a key mechanism in the pathogenesis of nasal polyposis in aspirin-sensitive asthmatics? Allergy 2003 58 : 95 7.
40. Pierzchalska M, Szabo Z, Sanak M, Soja J, Szczeklik A. Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients with special reference to aspirin-induced asthma. J Allergy Clin Immunol 2003 111 : 1041 8.